|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 August 2000, Vol. 96, No. 4, pp. 1558-1565
RED CELLS
Epolones induce erythropoietin expression via hypoxia-inducible
factor-1 activation
Roger M. Wanner,
Patrick Spielmann,
Deborah M. Stroka,
Gieri Camenisch,
Isabelle Camenisch,
Annette Scheid,
David R. Houck,
Christian Bauer,
Max Gassmann, and
Roland H. Wenger
From the Institute of Physiology, University of
Zürich-Irchel, Zürich, Switzerland; and OSI
Pharmaceuticals, MYCOsearch, Durham, NC.
Induction of erythropoietin (Epo) expression under hypoxic
conditions is mediated by the heterodimeric hypoxia-inducible factor (HIF)-1. Following binding to the 3' hypoxia-response element (HRE) of
the Epo gene, HIF-1 markedly enhances Epo transcription. To facilitate
the search for HIF-1 (ant)agonists, a hypoxia-reporter cell line
(termed HRCHO5) was constructed containing a stably integrated
luciferase gene under the control of triplicated heterologous HREs.
Among various agents tested, we identified a class of substances called
epolones, which induced HRE-dependent reporter gene activity in HRCHO5
cells. Epolones are fungal products known to induce Epo expression in
hepatoma cells. We found that epolones (optimal concentration 4-8 µmol/L) potently induce HIF-1 protein accumulation and nuclear
translocation as well as HIF-1 DNA binding and reporter gene
transactivation. Interestingly, the activity of a compound related to
the fungal epolones, ciclopirox olamine (CPX), was blocked after
addition of ferrous iron. This suggests that CPX might interfere with
the putative heme oxygen sensor, as has been proposed for the iron
chelator deferoxamine mesylate (DFX). However, about 10-fold higher
concentrations of DFX (50-100 µmol/L) than CPX were required to
maximally induce reporter gene activity in HRCHO5 cells. Moreover,
structural, functional, and spectrophotometric data imply a
chelator:iron stoichiometry of 1:1 for DFX but 3:1 for CPX. Because the
iron concentration in the cell culture medium was determined to be 16 µmol/L, DFX but not CPX function can be explained by complete
chelation of medium iron. These results suggest that the lipophilic
epolones might induce HIF-1 by intracellular iron chelation.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. Elser, L. Borsig, P. O. Hassa, S. Erener, S. Messner, T. Valovka, S. Keller, M. Gassmann, and M. O. Hottiger
Poly(ADP-Ribose) Polymerase 1 Promotes Tumor Cell Survival by Coactivating Hypoxia-Inducible Factor-1-Dependent Gene Expression
Mol. Cancer Res.,
February 1, 2008;
6(2):
282 - 290.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Barth, J. Nesper, P. A. Hasgall, R. Wirthner, K. J. Nytko, F. Edlich, D. M. Katschinski, D. P. Stiehl, R. H. Wenger, and G. Camenisch
The Peptidyl Prolyl cis/trans Isomerase FKBP38 Determines Hypoxia-Inducible Transcription Factor Prolyl-4-Hydroxylase PHD2 Protein Stability
Mol. Cell. Biol.,
May 15, 2007;
27(10):
3758 - 3768.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Fandrey, T. A. Gorr, and M. Gassmann
Regulating cellular oxygen sensing by hydroxylation
Cardiovasc Res,
September 1, 2006;
71(4):
642 - 651.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. E. Schweppe, T. H. Cheung, and N. G. Ahn
Global Gene Expression Analysis of ERK5 and ERK1/2 Signaling Reveals a Role for HIF-1 in ERK5-mediated Responses
J. Biol. Chem.,
July 28, 2006;
281(30):
20993 - 21003.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Martin, T. Linden, D. M. Katschinski, F. Oehme, I. Flamme, C. K. Mukhopadhyay, K. Eckhardt, J. Troger, S. Barth, G. Camenisch, et al.
Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation
Blood,
June 15, 2005;
105(12):
4613 - 4619.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Demougeot, M. Van Hoecke, N. Bertrand, A. Prigent-Tessier, C. Mossiat, A. Beley, and C. Marie
Cytoprotective Efficacy and Mechanisms of the Liposoluble Iron Chelator 2,2'-Dipyridyl in the Rat Photothrombotic Ischemic Stroke Model
J. Pharmacol. Exp. Ther.,
December 1, 2004;
311(3):
1080 - 1087.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Li, R. Issa, P. Kumar, I. N. Hampson, J. M. Lopez-Novoa, C. Bernabeu, and S. Kumar
CD105 prevents apoptosis in hypoxic endothelial cells
J. Cell Sci.,
July 1, 2003;
116(13):
2677 - 2685.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Hofer, R. H. Wenger, M. F. Kramer, G. C. Ferreira, and M. Gassmann
Hypoxic up-regulation of erythroid 5-aminolevulinate synthase
Blood,
January 1, 2003;
101(1):
348 - 350.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
